Lynx1 Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-544,001	Closed	-$8.61M	–	18
2024 Q4	$8.61M	Buy	+544,001	New	+$8.61M	3.23%	8